NCT00689325 Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics Status COMPLETED Phase N/A
NCT00686400 A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia Status UNKNOWN Phase N/A
NCT00686140 A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia Status COMPLETED Phase NA
NCT00685321 Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia Status UNKNOWN Phase NA
NCT00677898 A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) Status COMPLETED Phase NA
NCT00669903 Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia Status TERMINATED Phase PHASE2
NCT00668837 A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305. Status COMPLETED Phase PHASE3
NCT00666432 Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes Status COMPLETED Phase N/A
NCT00661869 Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness Status COMPLETED Phase NA
NCT00659919 Treatment of Neuroleptic Induced Acute Akathisia With Trazodone Status COMPLETED Phase PHASE4